1. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1
   Meiling Li et al, 2017, Biochemical and Biophysical Research Communications CrossRef
2. Melatonin‐triggered post‐transcriptional and post‐translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma
   Yu‐Ching Wen et al, 2020, Journal of Pineal Research CrossRef
3. ADAM and ADAMTS Family of Metalloproteinases: Role in Cancer Progression and Acquisition of Hallmarks
   Rajakishore Mishra et al, 2017, Proteases in Human Diseases CrossRef
4. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression
   Ruth Escalona et al, 2018, International Journal of Molecular Sciences CrossRef
5. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
   Bianfei Shao et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
6. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers
   Felix Kordowski et al, 2018, BMC Cancer CrossRef
7. Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in Gastric Cancer
   Liang Liang et al, 2020, Journal of Oncology CrossRef